Acteoside Ameliorates Hepatic Steatosis and Liver Injury in MASLD Mice Through Activation of PINK1/Parkin-Related Mitophagy Markers

Meili Cong, Xinxin Qi, Hongguang Sun, Xinxuan Zhang, Yunxin Yan, Tao Liu, Jun Zhao · 2025

Read Acteoside Ameliorates Hepatic Steatosis and Liver Injury in MASLD Mice Through Activation of PINK1/Parkin-Related Mitophagy Markers by Meili Cong, Xinxin Qi, Hongguang Sun, Xinxuan Zhang, Yunxin Yan, Tao Liu, Jun Zhao (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12787717.txt.

Description

Meili Cong and co-authors test in 2025 whether a plant compound called acteoside can ease fatty liver disease in mice, and whether it works by switching on a cell cleanup pathway. The compound is known for antioxidant and liver protective effects. Faulty cleanup of worn cell parts is thought to drive the disease. Mice fed a high fat, high sugar diet got the compound at three doses for fourteen weeks, with a standard drug group for comparison.

Treated mice showed better blood fats, liver function, and insulin response, with less fat stored in the liver on tissue checks. Signs of cell stress fell and protective enzymes rose. Marker proteins for the cleanup pathway rose as well, tying the benefit to that pathway.

Catalog record

CREATORMeili Cong, Xinxin Qi, Hongguang Sun, Xinxuan Zhang, Yunxin Yan, Tao Liu, Jun Zhao
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12787717

Browse the full library · About the Tower of Babel